Bulletin
Investor Alert

Olema Pharmaceuticals Inc.

NAS: OLMA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 14, 2022, 4:00 p.m.

/zigman2/quotes/222642382/composite

$

6.69

Change

0.00 0.00%

Volume

Volume 13,799

Quotes are delayed by 20 min

/zigman2/quotes/222642382/composite

Previous close

$ 6.56

$ 6.69

Change

+0.13 +1.98%

Day low

Day high

$6.27

$6.71

Open

52 week low

52 week high

$6.27

$54.88

Open

Annual Financials for Olema Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 201820192020 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A --8,2449,03311,000
COGS excluding D&A -----
Depreciation & Amortization Expense --8,2449,03311,000
Depreciation --8,2449,03311,000
Amortization of Intangibles -----
Gross Income --(8,244)(9,033)(11,000)
201820192020 5-year trend
SG&A Expense --2.07M4.31M21.52M
Research & Development --1.69M3.92M13.7M
Other SG&A --377,756393,9677.81M
Other Operating Expense -----
Unusual Expense --94,000--
EBIT after Unusual Expense --(2.17M)--
Non Operating Income/Expense -----
Non-Operating Interest Income --4,0007,00060,000
Equity in Affiliates (Pretax) -----
Interest Expense --28,000-653,000
Gross Interest Expense --28,000-653,000
Interest Capitalized -----
Pretax Income --(2.2M)(4.32M)(22.12M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income --(2.2M)(4.32M)(22.12M)
Minority Interest Expense -----
Net Income --(2.2M)(4.32M)(22.12M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries --(2.2M)(4.32M)(22.12M)
Preferred Dividends ----1.87M
Net Income Available to Common --(2.2M)(4.32M)(23.99M)
EPS (Basic) --(0.06)(0.11)(0.61)
Basic Shares Outstanding --37.52M40.17M39.31M
EPS (Diluted) --(0.06)(0.11)(0.61)
Diluted Shares Outstanding --37.52M40.17M39.31M
EBITDA --(2.07M)(4.31M)(21.52M)
Link to MarketWatch's Slice.